Prostate Apoptosis Response Gene-4 Sensitizes Neoplastic Lymphocytes to CD95-induced Apoptosis
Overview
Authors
Affiliations
Evaluating the functional consequences of prostate apoptosis response gene-4 (par-4) expression in CD95-induced apoptosis of neoplastic lymphocytes, we demonstrate that par-4 increases apoptosis by upregulating the CD95 receptor on the cell surface and--with a concomitant decrease of the FLICE-like inhibitory protein (FLIP)--by promoting cleavage of the initiator caspases-8 and -10. This results in an enforced activation of the executioner caspases-6, -7, and -3 as well as in an activation of the mitochondrial pathway. Upon inhibition of caspase-8, overexpression of par-4 enables Jurkat cells to maintain a higher sensitivity to CD95-induced apoptosis by downregulating cIAP-2 and XIAP and by enforcing activation of the initiator caspase-10 as well as of the executioner caspases-6, -7, and -3.
Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.
Cheratta A, Thayyullathil F, Pallichankandy S, Subburayan K, Alakkal A, Galadari S Cell Death Dis. 2021; 12(1):47.
PMID: 33414404 PMC: 7790818. DOI: 10.1038/s41419-020-03292-1.
TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells.
Nguyen J, Irby R Cancer Biol Ther. 2016; 18(1):16-25.
PMID: 27830973 PMC: 5323013. DOI: 10.1080/15384047.2016.1252880.
Jagtap J, Parveen D, Shah R, Desai A, Bhosale D, Chugh A FEBS Open Bio. 2015; 5:8-19.
PMID: 25685660 PMC: 4309838. DOI: 10.1016/j.fob.2014.11.005.
Sharma A, Kline C, Berg A, Amin S, Irby R Clin Cancer Res. 2011; 17(13):4474-83.
PMID: 21555373 PMC: 3131476. DOI: 10.1158/1078-0432.CCR-10-2370.
Wang B, Kline C, Pastor D, Olson T, Frank B, Luu T Mol Cancer. 2010; 9:98.
PMID: 20433755 PMC: 2883962. DOI: 10.1186/1476-4598-9-98.